People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Salutaris Medical Devices Inc | — | Biotechnology | Seed | $5.4M | $6.4M | 2009 |
| MitoChem Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $236K | $10.0M | 2020 |
Michael Voevodsky at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Voevodsky on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Love | 1 | 5 |
| WILLIAM LOMICKA | 1 | 4 |
| Akiteru Furukawa | 1 | 3 |
| Eric Tooker | 1 | 3 |
| George Mimura | 1 | 2 |
| Baerbel G. Rohrer | 1 | 1 |
| Gyda Caren Beeson | 1 | 1 |
| Ryan Lohrenz | 1 | 1 |
| Laurence Marsteller | 1 | 1 |
| William Mumma | 1 | 1 |
| Robert Selby | 1 | 1 |
| Rick G. Schnellman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.